Maqola mavzusi

Mualliflar

Ражаббоев А.А.

Muassasa

Тошкент давлат тиббиёт университети, Тошкент ш., Ўзбекистон

Annotatsiya

Тухумдон ўсмалари аёллар орасида энг кўп учрайдиган гинекологик касалликлардан бири бўлиб, уларнинг патоморфологик ва морфометрик хусусиятлари диагностика ва даволашда муҳим аҳамиятга эга. Жаҳон соғлиқни сақлаш ташкилотининг (ЖСТТ) 2020 йилги таснифига кўра, тухумдон ўсмалари асосан сирт эпителий, жинсий ҳужайра, жинсий шнур-строма ва метастатик турларга бўлинади. Ушбу мақолада ўсмаларнинг гистологик турлари, морфометрик ўлчовлари, миқдорий таҳлили, молекуляр маркерлар, риск факторлари, клиник кўринишлари, диагностика, даволаш ва прогноз таҳлил қилинган. Долзарблиги шундаки, тухумдон саратони аёллар ўлимининг етакчи сабабларидан бири бўлиб, эрта диагностика ва морфологик таҳлил орқали ҳаётни сақлаб қолиш мумкин. Мақола реал юқори импактли базаларда индексланган манбалардан фойдаланиб, шарҳ шаклида таҳрирланган.

Kalit so'zlar

тухумдон ўсмалари, патоморфология, морфометрия, гистологик тасниф, миқдорий таҳлил, молекуляр маркерлар, эпидемиология

Adabiyotlar

1. Patel, A. S., Patel, J. M., & Shah, K. J. (2018). Ovarian tumors-Incidence and histopathological spectrum in tertiary care center, Valsad. International Archives of Integrated Medicine, 5(2), 84-93.
2. Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), 17-48. https://doi.org/10.3322/caac.21763
3. Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229-263. https://doi.org/10.3322/caac.21834
4. World Ovarian Cancer Coalition. (2023). The World Ovarian Cancer Coalition Atlas 2023. https://worldovariancancercoalition.org/wp-content/uploads/2023/04/World-Ovarian-Cancer-Coalition-Atlas-2023-FINAL.pdf
5. WHO Classification of Tumours Editorial Board. (2020). Female genital tumours (5th ed., Vol. 4). International Agency for Research on Cancer.
6. De Leo, A., Santini, D., Ceccarelli, C., Santandrea, G., Palicelli, A., Acquaviva, G., Federico, A., Bonaccorsi, G., & Mandato, V. D. (2021). What is new on ovarian carcinoma: Integrated morphologic and molecular analysis following the new 2020 World Health Organization classification of female genital tumors. Diagnostics, 11(4), 697. https://doi.org/10.3390/diagnostics11040697
7. Kaku, S., Takeshima, N., Tanaka, H., Matsubara, Y., Ueda, H., Shitano, F., Kuramoto, K., Miyagi, H., Nagayoshi, Y., Shigeta, S., Tamura, R., Kawana, K., & Takeshita, T. (2023). Histomorphological analysis of ovarian neoplasms according to the 2020 WHO classification of ovarian tumors: A distribution pattern in a tertiary care center. Cureus, 15(3), e35671. https://doi.org/10.7759/cureus.35671
8. Giovannopoulou, E., Koros, C., Thomopoulos, T., Charalabopoulos, K., & Giannakis, D. (2023). Ovarian morphometric and histologic characteristics and their associations with natural fertility and assisted reproduction outcomes: A comprehensive review. Journal of Personalized Medicine, 13(2), 232. https://doi.org/10.3390/jpm13020232
9. Prat, J., D'Angelo, E., & Espinosa, I. (2018). Ovarian carcinomas: At least five different diseases with distinct histological features and molecular genetics. Human Pathology, 80, 11-27. https://doi.org/10.1016/j.humpath.2018.06.003
10. Kurman, R. J., & Shih, I. M. (2010). The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. American Journal of Surgical Pathology, 34(3), 433-443. https://doi.org/10.1097/PAS.0b013e3181cf3d79
11. McCluggage, W. G., Singh, N., Kommoss, F., Huntsman, D. G., & Gilks, C. B. (2022). Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020). Histopathology, 80(5), 762-778. https://doi.org/10.1111/his.14609
12. Kim, M. J., Suh, D. H., Lee, K. H., Eom, K. Y., Toftdahl, N. G., Mirza, M. R., & Kim, J. W. (2019). Major clinical research advances in gynecologic cancer in 2018. Journal of Gynecologic Oncology, 30(2), e18.
13. McMullen, M., Madariaga, A., & Lheureux, S. (2021). New approaches for targeting platinum-resistant ovarian cancer. Seminars in Cancer Biology, 77, 167-181.
14. Folkins, A. K., & Longacre, T. A. (2013). Hereditary gynaecological malignancies: Advances in screening and treatment. Histopathology, 62(1), 2-30. https://doi.org/10.1111/his.12028
15. Girolimetti, G., Perrone, A. M., Santini, D., Barbieri, E., Guerra, F., Ferrari, S., Zamagni, C., De Iaco, P., Gasparre, G., & Turchetti, D. (2014). BRCA-associated ovarian cancer: From molecular genetics to risk management. BioMed Research International, 2014, 787143.
16. Soslow, R. A., Han, G., Park, K. J., Garg, K., Olvera, N., Spriggs, D. R., Kauff, N. D., & Levine, D. A. (2012). Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Modern Pathology, 25(4), 625-636. https://doi.org/10.1038/modpathol.2011.183
17. Köbel, M., Piskorz, A. M., Lee, S., Lui, S., LePage, C., Marass, F., Rosenfeld, N., De Fazio, A., & Brenton, J. D. (2016). Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. The Journal of Pathology: Clinical Research, 2(4), 247-258. https://doi.org/10.1002/cjp2.53
18. Santandrea, G., Piana, S., Valli, R., Zanelli, M., Gasparini, E., De Leo, A., Mandato, V. D., & Palicelli, A. (2021). Immunohistochemical biomarkers as a surrogate of molecular analysis in ovarian carcinomas: A review of the literature. Diagnostics, 11(2), 199.
19. Hussein, Y. R., Soslow, R. A., & Kezlarian, B. E. (2016). Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube origin. American Journal of Surgical Pathology, 40(3), 404-409.
20. Darb-Esfahani, S., Kolaschinski, I., Trillsch, F., Mahner, S., Concin, N., Vergote, I., Van Nieuwenhuysen, E., Achimas-Cadariu, P., Glajzer, J., Woopen, H., Wienert, S., Siegmund, B., Budczies, J., Schmitt, W., Darb-Esfahani, S., Braicu, E. I., Schraml, P., Budczies, J., Denkert, C., & Kulbe, H. (2018). Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival. Histopathology, 73(6), 1002-1012.